about
Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-AnalysisA Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease PathogenesisThe endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive diseaseEmerging roles of the neuronal nucleolusNeuropathological alterations in Alzheimer diseaseCognitive and social lifestyle: links with neuropathology and cognition in late lifeManganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primatesRedox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the ratEpigenetic silencing of nucleolar rRNA genes in Alzheimer's disease.Genetic mutations linked to Parkinson's disease differentially control nucleolar activity in pre-symptomatic mouse modelsResilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition.Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.An overview of APP processing enzymes and products.Distinct cerebral perfusion patterns in FTLD and ADRegional Fluid-Attenuated Inversion Recovery (FLAIR) at 7 Tesla correlates with amyloid beta in hippocampus and brainstem of cognitively normal elderly subjects.Genetic modification of the relationship between phosphorylated tau and neurodegeneration.Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA)Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3 TIs there a neuropathology difference between mild cognitive impairment and dementia?Amyloid imaging and memory change for prediction of cognitive impairment.Cerebral blood flow measured by arterial spin labeling MRI as a preclinical marker of Alzheimer's disease.Advances in the prevention of Alzheimer's disease and dementiaAsymptomatic Alzheimer's disease: a prodrome or a state of resilience?Amyloid-β immunization enhances neurogenesis and cognitive ability in neonatal mice.APOε2 and education in cognitively normal older subjects with high levels of AD pathology at autopsy: findings from the Nun StudyPreserved neurogenesis in non-demented individuals with AD neuropathology.Longitudinal brain activity changes in asymptomatic Alzheimer diseaseAbsence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.Neuropathological approaches to cerebral aging and neuroplasticity.Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?DNA-dependent protein kinase and DNA repair: relevance to Alzheimer's disease.Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.Impaired rRNA synthesis triggers homeostatic responses in hippocampal neurons.Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease.The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life.Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition.
P2860
Q26768181-091A3397-B8BC-4C70-8F0D-AA168D845BCDQ26781496-127A754C-CDDD-40A9-A7E0-A01DD52726B6Q26799258-206A49D6-4F75-4BA8-8FD1-1627B7C3C6CEQ26863209-CD08617F-9A0E-49BD-95E8-6883DB88EE96Q27003314-6C2CA7AE-D990-499B-836D-36ED1D0BDED8Q28304421-C93894A7-26C7-40D4-83C6-7E91CDD20991Q28384717-28EB7994-F8F4-469C-8809-4DC8D8796823Q30446460-70AE0A99-864A-47B9-8CCC-24D559F3A793Q30585312-120D36E9-18FD-4BDF-8D44-EEEE8D928720Q31028501-F11E9CCA-DB36-4982-A219-16D07AB6E723Q33746268-F3D61395-29E8-463B-B8A8-493BFB071183Q33766569-95A35511-88EB-4160-B553-8989357D356FQ33772805-7521D27E-1F97-4FA8-951D-7B7635162C8FQ33927819-A0130C06-28F0-4FE3-8059-858883453591Q34125576-966BA4FC-319F-46D0-A8C3-D63FC5FA5060Q34154830-ED2EE69A-7203-42ED-98FD-F1A62C11F8C8Q34216985-50BF22B6-FA91-4970-8635-8634DD1E62C6Q34298372-8891220E-F3B6-4E9F-9F44-91FE7B5C60E6Q34566376-27722988-23A4-42E1-A77F-950ADE5F2305Q34741172-50215C51-767A-40AC-94C1-2243824C450DQ34776816-1093509C-7E92-48F4-9A94-9B1AE9E60B3AQ35029095-7B3C28FE-3E89-4485-89E5-E43881515A37Q35232491-D6A338D1-3713-4FE9-BD92-369CC3F26F2CQ35322167-B246C586-E511-42E5-B799-C23437AC596CQ35778791-F42688AE-9D56-4B3E-B736-134C494D49B7Q35792042-0CE20A6B-512C-4BFD-8406-16039E85AFE0Q35987278-AB6B0848-1511-4916-91E6-F5091B7D5F3FQ36051333-AF3EE715-F79E-4F22-B067-FBCBBCEFB21BQ36053899-402957B8-77FB-4645-97FC-86204D90D714Q36112830-5A835578-AB64-4FE3-83A8-0CE3829484DCQ36339048-920A8A2D-49AA-4BE7-A2A2-6F0FFAC61394Q36755159-206E8249-8A79-4C85-96AC-B9E4E351A2F9Q36942803-5583C640-3574-4D1E-BB4B-EA51298A8571Q36998015-037DA8C0-C493-4F36-BDAC-0E70093161A3Q37043088-5DC646E6-FF3C-4DEA-8160-1205F3AA4A4BQ37295592-3927FF0E-FD23-4985-8C92-DAF4575F6C44Q37319974-D337BD3F-360C-4E8D-8F37-D841A2C4AF17Q37324689-283853DC-F656-4DAF-8562-EB187BA3A0EDQ37332710-2792F94A-AED5-4221-B74F-13F3A7639342Q37589292-31C34CE7-0646-4E29-9FEC-2B6638F2D21A
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Neuronal hypertrophy in asymptomatic Alzheimer disease.
@en
type
label
Neuronal hypertrophy in asymptomatic Alzheimer disease.
@en
prefLabel
Neuronal hypertrophy in asymptomatic Alzheimer disease.
@en
P2093
P2860
P1476
Neuronal hypertrophy in asymptomatic Alzheimer disease.
@en
P2093
Barbara Crain
Diego Iacono
Juan C Troncoso
Mark J West
Olga Pletnikova
Richard O'Brien
Susan M Resnick
P2860
P304
P356
10.1097/NEN.0B013E3181772794
P577
2008-06-01T00:00:00Z